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SUMMARY We investigated the hemodynamics of the greater and lesser circulation in 35 patients with
primary hypertension, as well as the effects of calcium-channel blockade, to test whether a common factor
may account for the excessive vascular resistance in the two circuits and whether intracellular calcium
concentration ([Ca++]i) may be involved. We proved that (1) elevated pulmonary arteriolar resistance
(PAR) is not related to pulmonary blood flow and volume, pleural pressure, arterial oxygen or carbon
dioxide tension and pH, left ventricular filling pressure and function; (2) systemic vascular resistance (SVR)
significantly correlates with PAR; (3) calcium-channel blockade with nifedipine reduces systemic and
pulmonary arterial pressures toward normal and significantly lowers both SVR and PAR; (4) the percent
decrease in vascular resistance after nifedipine is related to the baseline level of resistance in both the
greater and the lesser circulations.
Failure of the mechanisms currently indicated as responsible for pulmonary vasoconstriction to explain
convincingly the increased PAR, the correlation between SVR and PAR, as well as the qualitatively similar
response to calcium-channel blockade suggest that a common factor produces vasoconstriction in the two
circuits. A pathogenetic role of a primary disorder in [Ca++]i cannot be excluded, but remains to be
proved.
BLOOD PRESSURE elevation in most patients with
chronic hypertension is associated with increased pe-
ripheral vascular resistance, which is due in part to
abnormal constriction of the resistance vessels.' For a
time, the autoregulatory theory4 was popular. Interest
has now focused on the hypothesis that an excessive
intracellular calcium-ion concentration ([Ca++]i) is
the proximate cause of the disordered vasomotility.f
This view is based on two fundamental concepts: that
in smooth muscle,6 7 as in striate muscle,8 calcium ions
trigger contraction, and that sodium-calcium exchange
plays a critical role in the control of [Ca' +]i and in the
tension regulation of vascular smooth muscle.9 In hy-
pertension, an increase in sodium gradient across the
sarcolemma is reflected as an increase in [Ca +]i and
therefore in steady wall tension and peripheral vascular
resistance.'
For intracellular sodium to be raised, the delicate
mechanisms that are located in the membrane and reg-
ulate the sodium and potassium content of the cell must
be disturbed. Several investigators have described a
defect in ion transport across the erythrocyte mem-
brane in animal hypertension,'0 as well as in red' -14
and white blood cells'5 of patients with essential hyper-
tension or of their normotensive offspring. 16 17 Impair-
ment of the sodium pump has been found by some
workers,'5 and a deficiency in the Na+/K+ cotransport
system has been described by others."' As related to
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hypertension, these disorders are spread throughout
the body and involve arteriolar smooth muscle, which
is the actual culprit. Unfortunately, blood cells, which
can be easily studied, are not related at all to the mus-
cles of the vessel wall, and the theory of abnormal
membrane cation transport, although attractive, will
remain speculative, until more is known about the me-
tabolism of this tissue in essential hypertension.
Based on previous observations'8-20 that pressure
and arteriolar resistance in the pulmonary circulation
are increased in systemic high blood pressure, we de-
cided to investigate the hemodynamics of the lesser
circulation in hypertension to determine whether there
is a common factor that accounts for the vasoconstric-
tion that involves the two circuits and whether intracel-
lular calcium is involved.
Materials and Methods
Subjects
Thirty-five hospitalized men with primary arterial
hypertension were investigated. All had blood pres-
sure readings persistently above 180/100 mm Hg by
sphygmomanometer. Uncomplicated essential hyper-
tension was diagnosed from the patient's medical his-
tory and ordinary clinical tests. Criteria for selection of
patients were absence of symptoms or signs of heart
failure, pulmonary disease, valvular lesions, anginal
pain, old myocardial infarction, idiopathic myocardial
disese in addition to hypertension; glomerular filtra-
tion rate above 70 ml/min; normal serum concentration
of sodium, potassium and chloride; regular sinus
rhythm without conduction defects; no digitalis at any
time in the past or antihypertensive therapy for at least
3 weeks before entry; no urgent need for treatment; and
a technically satisfactory left ventricular echocardio-
gram. After receiving detailed information on the pro-
cedures and the possible clinical benefits, all patients
consented to participate in the investigation.
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Baseline variables measured in these patients were
compared with those in 14 normotensive subjects of
similar age investigated previously.21 These controls
were healthy volunteers or patients in the hospital who
had no signs of circulatory disorders and were not
taking medications that could interfere with their car-
diovascular function. The echocardiographic and he-
modynamic techniques used in this study have been
reported in detail.20
Ultrasound Methods
Echocardiography was carried out with an ECHO-
Cardio-VISOR (Organon-Teknika) ultrasound unit.
Patients were recumbent in a slight lateral decubitus
position. The left ventricular internal dimensions were
measured at end-diastole simultaneously with the R
wave of the ECG and at end-systole when posterior
wall and septum maximally approached each other; the
distance was taken from the endocardial echo of the
posterior wall to the echo of the left side of the septum.
The normalized mean velocity of left ventricular cir-
cumferential fiber shortening (circ/sec) was derived
from the equation
Dl- -S d
LVET x Dd
where Dd is the end-diastolic diameter, S is the end-
systolic diameter and LVET is the left ventricular ejec-
tion time.
Endovascular Techniques
Hemodynamic measurements were performed with
the patients in the fasting state and supine; no premedi-
cation was given. A #7 flow-directed Swan-Ganz
catheter was inserted percutaneously into an antecubi-
tal vein, floated to the pulmonary artery and advanced
to the wedge position. A #6 polyethylene radiopaque
catheter introduced into a brachial artery and advanced
to the root of the aorta was used to monitor arterial
pressure and to sample blood for cardiac output deter-
minations. Reproducible dye-dilution curves were ob-
tained by Gilford densitometer after rapid injection of
indocyanine green dye (5 mg) into the main pulmonary
artery just beyond the pulmonary valve. The area
under each dye-dilution curve was measured by pla-
nimetry; cardiac output and pulmonary blood volume
were calculated by the method of Hamilton et al.''
Pressures were determined with Statham P23De and
P23Db strain-gauge transducers, which were balanced
against atmospheric pressure. The zero reference level
for pressure recordings was 5 cm below the sternal
angle. Mean pressures were obtained by electronic
damping. The left ventricular ejection time was mea-
sured by recording the aortic pressure tracing on an
eight-channel Gould-Brush ink recorder (model 480)
at a paper speed of 100 mm/sec. The interval was
calculated from the mean of five consecutive beats,
each read to the nearest 5 msec. Systemic vascular
resistance (SVR) and pulmonary arteriolar resistance
(PAR) were calculated from the following formulas:
SVR AP - RAP x 1332 x 60
CO (ml/min)
PAR
PP - PWP x 1332 x 60
CO (ml/min)
where AP = mean aortic_pressure, PP = mean pulmo-
nary arterial pressure, RAP = mean right atrial pres-
sure, PWP - mean pulmonary arterial wedge pressure
and CO - cardiac output.
Respiratory Techniques
Pleural pressure was estimated by the method of
Milic-Emili et al.> In brief, a rubber 2-mi esophageal
balloon was introduced through the nose into the
esophagus, placed 45 cm from the balloon tip to the
nares, and connected to a pressure transducer through a
polyethylene tube. Pleural pressure and circulatory
variables were recorded simultaneously on the same
recording system during quiet regular respiration.
Oxygen and carbon dioxide tensions and pH were de-
termined from an arterial blood sample drawn during
quiet regular respiration. The pH was determined
using the apparatus described by Siggaard-Andersen et
al. 3 The Pco, was obtained with the nomogram also
described by Siggaard-Andersen et al. Oxygen ten-
sion was determined with a Radiometer Po, electrode
(type E 5046). The final values for each subject were
the average of three measurements.
Procedures
Essential hypertension was diagnosed after admis-
sion to the hospital. The patients were given a standard
hospital diet (approximately 100 mEq sodium/day)
and were familiarized with the laboratory and the in-
vestigators to minimize the possible interference of
emotional factors. Then, echocardiographic, hemo-
dynamic and respiratory evaluation was performed and
the circulatory response to a calcium-channel blocking
agent (nifedipine, 10 mg sublingually) was tested. All
of the steady-state measurements were performed
when patients felt comfortable and heart rate and pres-
sures had stabilized, at least 30 minutes after the endo-
vascular procedures were completed. The baseline he-
modynamic variables were measured 30 minutes and 5
minutes before nifedipine was given. The average of
the two measurements was taken as the representative
value of each subject. Aortic and pulmonary pressures
and heart rate were monitored continuously during the
30 minutes before and the 120 minutes after nifedi-
pine. Right atrial pressure, pulmonary wedge pressure
and cardiac output were measured again 30, 60 and
120 minutes, respectively, after nifedipine.
The hypertensive patients were separated into two
groups, according to the absence (group 1. 18 patients)
or the presence (group 2, 17 patients) of left ventricular
enlargement determined echocardiographically. The
left ventricular end-diastolic minor axis was within
control limits in group 1 and exceeded 1 standard devi-
ation of control in group 2. This difference was used to
define the possible backward influence of left ventricu-
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TABLE 1. Pleural Pressure, Pulmonary Blood Volume and Arte-
rial Oxygen Tension, Carbon Dioxide Tension and pH
Control Hypertensive patients
subjects Group 1 Group 2
Pleural pressure
(mm Hg)
Inspiratory -5.7 ±O .94 -5.63 ±O .99 -5.59± 0.93
Expiratory -2.03 + 0.7 -1.97 + 0.69 -2.05 ± 0.71
Pulmonary blood
volume (ml) 1161 ± 221 1194 ± 309 1235 ± 278
Po2 91.7 ± 2.6 90.8 ± 2.6 92.3 ± 2.9
Pco1 35.07 ± 2.6 35.25 + 2.5 34.23 + 3.01
pH 7.433 7.436 7.428
Values are average + SD.
The differences between hypertensive groups and control sub-
jects are statistically not significant.
Abbreviations: Pou = arterial oxygen tension; Pco, = arterial
carbon dioxide tension.
lar function on pulmonary hemodynamics, as the per-
formance of the hypertensive left ventricle is preserved
or enhanced when its dimensions are normal, and con-
sistently compromised when it is enlarged.24
Statistical Analysis
The statistical significance of the differences be-
tween normal subjects and hypertensives, between the
two hypertensive groups, and between values before
and after nifedipine was evaluated by analysis of vari-
ance on a Hewlett Packard desktop computer.
Results
Age and body surface area were comparable in the
two hypertensive groups and in the control group. Pul-
mm Hg
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monary blood volume, pleural pressure, respiratory
gases and pH of the blood were also similar in the three
groups (table 1).
The average values of the hemodynamic variables
are reported in figure 1. Systemic systolic and diastolic
arterial pressures were elevated to a similar degree in
groups 1 and 2; since cardiac index was normal in the
former and reduced in the latter, systemic vascular
resistance was elevated in both groups, with a higher
level in group 2. Averages of systolic, diastolic and
mean pulmonary wedge pressures were relatively
similar in the two hypertensive groups and significant-
ly higher than normal; pulmonary arteriolar resistance
was elevated in group I and to a larger extent in group
2. The mean velocity of circumferential fiber shorten-
ing was significantly enhanced in group 1 and reduced
in group 2.
Figure 2 shows the systemic vascular resistance in
each hypertensive patient plotted against pulmonary
arteriolar resistance. The correlation between the two
variables is significant (p < 0.01).
The time course of the average percent circulatory
variations from baseline induced by nifedipine in hy-
pertensive patients is shown in figure 3. In group 1, 30
minutes after administration of the drug, mean system-
ic arterial pressure was reduced by 15% and mean
pulmonary arterial pressure was reduced by 6%. These
reductions were mediated through a 30% decrease in
systemic arteriolar resistance and a 17% decrease in
pulmonary arteriolar resistance, associated with a 22%
increase in cardiac index. Cardiac index increased be-
cause heart rate and stroke index increased. Although
some recovery was observed, these circulatory vari-
ations were still consistently evident 120 minutes after
nifedipine. In group 2, the response to calcium-ion
FIGURE 1. Hemodynamic functions in 14
1normotensive control subjects (C) and in two
groups ofpatients with essential hypertension:
group 1, 18 patients with normal-sized left
ventricle; and group 2, 17 patients with left
ventricular enlargement. Bars represent the
mean for the group (+ .SD). *p < 0.05; **p
< 0.01 for differences between the hyperten-
sive groups and the control subjects. The p
valuesfor differences betveen the hypertensive
groups are indicated in the figure. SPP =
v. systolic pulmonary pressure; DPP = diastolic
pulmonary pressure; PAR pulmonarv arte-
riolar resistance; SAP systolic arterial
pressure; DAP = diastolic arterial pressure;
SVR = systemic vascular resistance; PWP =
[_i mean pulmonary wedge pressure; CI = cardi-j.~ ac index; Vcf - left ventricular mean velocity
O ; of circumferential fiber shortening.
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blockade was qualitatively similar to
but was characterized by a significai
crease in systemic (- 40%) and pulm
resistance (- 30%) at 30 minutes, w
greater increase in cardiac index, cau
duction in mean systemic ( - 20%) an
nary arterial pressure (- 14%). The c
ations after calcium blockade remain
greater than in group 1 at both 60 an
Discussion
Pulmonary systolic and diastolic
equivalent among the hypertensives a
higher than in the normotensives. Car
normal in group 1 and reduced in grc
0 driving pressure across the lung was augmented in both
groups, pressure elevation in the pulmonary artery
depended on an increased pulmonary arteriolar
resistance.
0
Factors of different origin are conceivably involved
in a change in pulmonary arteriolar resistance: pulmo-
nary blood flow and volume, intrathoracic and alveolar
o pressures, left ventricular function, respiratory gases,
autonomic nervous system, and vasomotor sub-
° stances.25- 26 Respiratory gases, the pH of the blood,
and the pulmonary blood volume probably were not
responsible for an altered pulmonary vasomotility, as
they were similar in hypertensive and control subjects.
Blood flow also seems unrelated to changes in pulmo-
nary arteriolar resistance, as it was normal in one
group and reduced in the other, while resistance was
elevated in both groups. Pleural pressure estimated by
. esophageal balloon during quiet, regular respiration
was equivalent in the three groups; alveolar pressure
was not determined, but no reason was seen for an
SVR) and pulmo- increase in hypertensive patients. Therefore, extra-
ated subjects with mural pressures can also be excluded as important de-
,nts with a normal- terminants of the differences between control and hy-
h left ventricular pertensive patients. Elevation of left ventricular
diastolic pressure may account for an increase in pul-
monary arteriolar resistance. However, Atkins and
that in group 1, collaborators'8 reported that in patients suffering from
ntly greater de- systemic hypertension, pulmonary vascular resistance
ionary arteriolar is highly correlated with pulmonary wedge pressure
rhich, despite a greater than 20 mm Hg, but not with pulmonary wedge
sed a larger re- pressure lower than 20 mm Hg, even though many
id mean pulmo- patients with lower wedge pressures had an increased
virculatory vari- pulmonary vascular resistance. In our hypertensive
led significantly population, the pulmonary wedge pressure was less
Id 120 minutes. than 20 mm Hg and no correlation was found between
the two variables. Finally, the pattern of the mean
velocity of circumferential fiber shortening shows that
pressures were cardiac muscle performance was compromised in
ind significantly group 2 and enhanced in group 1, which confirms
-diac output was previous findings of opposite functional changes in the
Dup 2; since the normal-sized hypertensive heart compared with the en-
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FIGURE 3. Average (+ SD) percent vari-
ations from baseline at various periods after
nifedipine (10 mg) of mean systemic (MSAP)
and pulmonary (MPAP) arterial pressures,
systemic (SVR) and pulmonary (PAR) vascular
resistance, cardiac index (CI), stroke index
(SI) and heart rate (HR) in untreated patients
with primary hypertension (group 1, 18 sub-
jects with normal sized left ventricle; group 2,
17 subjects with left ventricular enlargement).
*p < 0.01 vs baseline. **p < 0.01 vs group 1
at the same period.
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larged one.' 4 Apart from the intriguing mechanisms
underlying these patterns, circumferential fiber short-
ening velocity values in groups I and 2 reasonably rule
out the possibility that the elevated pulmonary arterio-
lar resistance in either group depends on left ventricu-
lar function.
A quantitative relationship exists in the averages of
pulmonary and systemic vascular resistance in the two
hypertensive groups, which suggests the alternative
explanation that a common mechanism may produce
vasoconstriction in the greater and in the lesser circula-
tion. This possibility is strengthened by the significant
correlation found when systemic vascular resistance
was plotted against pulmonary arteriolar resistance
(fig. 2).
Referring to the pathogenetic role of calcium in hu-
man hypertension, the ability of nifedipine to reduce
high blood pressure toward normal through vasodilata-
tion27`29 does not seem as important as originally sug-
gested."' In fact, since intracellular calcium is a phys-
iologic mediator of the resting vascular smooth muscle
tone,6 ' which is normally maintained in most resis-
tance vessels, a vasodilating effect and some degree of
blood pressure reduction after calcium-channel block-
ade with either nifedipine32 or verapamil-33 also occurs
in normotensive subjects. Consequently, the antihy-
pertensive response to nifedipine, per se, does not al-
low us to discern whether it is caused by withdrawal of
a physiologic factor or whether a disorder in [Ca' ]i
actually promotes the exaggerated vascular tone. Fig-
ure 3 shows that nifedipine lowers blood pressure in
both the greater and the lesser circulation through va-
sodilatation, which involves systemic and pulmonary
arterioles to a degree that, in either circuit, is propor-
tional to the baseline levels of vascular resistance. Fol-
kow34 emphasized the structural changes in arterial and
arteriolar walls in hypertension, and pointed out that an
increased wall:lumen ratio can have a progressive
pressor effect, and accentuate the superimposed vascu-
lar tone adjustments correspondingly. Thereby, sub-
traction of the physiologic vascular tone through cal-
cium blockade might lower blood pressure in
proportion to the structural vascular changes. This in-
terpretation might explain results in systemic circula-
tion; whether it fits our findings in pulmonary circula-
tion remains matter of dispute, as information on the
structure of the pulmonary vessels in hypertension is
lacking.
The ratios of the rate coefficients for fluxes of Na'
and Ca' + across sarcolemma and for sarcolemmal so-
dium-calcium exchange play a critical role in the regu-
lation of the steady-state intracellular Ca' + concentra-
tion. Factors that influence these ratios may, therefore.
be important determinants of the vascular smooth fiber
tension and blood pressure. Disorders in sodium and
calcium permeability and transport in vessel smooth
muscle and vasoconstrictor agents such as norepineph-
rine are examples of such factors. Norepinephrine
tends to increase the mean ICa++]i through an aug-
mented permeability of the sarcolemma to sodium35
and, perhaps, to calcium36 and by triggering the release
of calcium from the sarcoplasmic reticulum. " An ex-
cessive adrenergic drive or catecholamine release as a
basic mechanism for the vasoconstriction in primary
high blood pressure in man might explain the antihy-
pertensive effect of calcium-blocking agents. but this
theory, although extensively debated, has never been
proved.
In conclusion, failure to explain convincingly the
increased pulmonary arteriolar resistance through the
mechanisms that are currently considered responsible
for pulmonary vasoconstriction, the significant corre-
lation between systemic and pulmonary vascular resis-
tance, together with the qualitatively similar response
to calcium-channel blockade, consistently suggest the
possibility that a common factor causes vasoconstric-
tion in the two circuits in patients with systemic hyper-
tension. These data do not rule out the possibility that a
disordered [Ca' -i is a shared mechanism for the aug-
mented vascular tone; however, the pathogenetic role
of calcium remains to be proved.
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